262 related articles for article (PubMed ID: 28781336)
1. Serum Eosinophil Cationic Protein Is a Useful Marker for Assessing the Efficacy of Inhaled Corticosteroid Therapy in Children with Bronchial Asthma.
Guo CL; Sun XM; Wang XW; Guo Q
Tohoku J Exp Med; 2017 Aug; 242(4):263-271. PubMed ID: 28781336
[TBL] [Abstract][Full Text] [Related]
2. Elevated fractional exhaled nitric oxide (FeNO) is a clinical indicator of uncontrolled asthma in children receiving inhaled corticosteroids.
Yin SS; Liu H; Gao X
Int J Clin Pharmacol Ther; 2017 Jan; 55(1):66-77. PubMed ID: 27443657
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
[TBL] [Abstract][Full Text] [Related]
4. Correlation Between Fractional Exhaled Nitric Oxide Levels and Efficacy of Inhaled Corticosteroids in Children With Bronchial Asthma.
Gao SJ; Ge YP; Zhang CJ
Am J Ther; 2018; 25(6):e617-e625. PubMed ID: 26990963
[TBL] [Abstract][Full Text] [Related]
5. Effect of inhaled steroid therapy on exhaled nitric oxide and bronchial responsiveness in children with asthma.
Nishio K; Odajima H; Motomura C; Nakao F; Nishima S
J Asthma; 2006 Dec; 43(10):739-43. PubMed ID: 17169825
[TBL] [Abstract][Full Text] [Related]
6. Association of symptom control with changes in lung function, bronchial hyperresponsiveness, and exhaled nitric oxide after inhaled corticosteroid treatment in children with asthma.
Park GM; Han HW; Kim JY; Lee E; Cho HJ; Yoon J; Hong SJ; Yang SI; Yang HJ; Yu J
Allergol Int; 2016 Oct; 65(4):439-443. PubMed ID: 27160342
[TBL] [Abstract][Full Text] [Related]
7. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.
Chu YT; Chiang W; Wang TN; Hung CH; Jong YJ; Wu JR
J Microbiol Immunol Infect; 2007 Apr; 40(2):162-7. PubMed ID: 17446966
[TBL] [Abstract][Full Text] [Related]
8. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-α, interleukin-8 and eosinophil cationic protein as serum markers of glucocorticoid efficacy in the treatment of bronchial asthma.
Ren J; Sun Y; Li G; Zhu XJ; Cui JG
Respir Physiol Neurobiol; 2018 Dec; 258():86-90. PubMed ID: 29908291
[TBL] [Abstract][Full Text] [Related]
10. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.
Kanemitsu Y; Matsumoto H; Izuhara K; Tohda Y; Kita H; Horiguchi T; Kuwabara K; Tomii K; Otsuka K; Fujimura M; Ohkura N; Tomita K; Yokoyama A; Ohnishi H; Nakano Y; Oguma T; Hozawa S; Nagasaki T; Ito I; Oguma T; Inoue H; Tajiri T; Iwata T; Izuhara Y; Ono J; Ohta S; Tamari M; Hirota T; Yokoyama T; Niimi A; Mishima M
J Allergy Clin Immunol; 2013 Aug; 132(2):305-12.e3. PubMed ID: 23791506
[TBL] [Abstract][Full Text] [Related]
11. Influence of cigarette smoking on airway inflammation and inhaled corticosteroid treatment in patients with asthma.
Shimoda T; Obase Y; Kishikawa R; Iwanaga T
Allergy Asthma Proc; 2016 Jul; 37(4):50-8. PubMed ID: 27401308
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum levels of TNF-α, IL-8, and ECP can be involved in the development and progression of bronchial asthma.
Jiang XG; Yang XD; Lv Z; Zhuang PH
J Asthma; 2018 Feb; 55(2):111-118. PubMed ID: 28399677
[TBL] [Abstract][Full Text] [Related]
13. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma.
Wever AM; Wever-Hess J; Hermans J
Clin Exp Allergy; 1997 May; 27(5):519-29. PubMed ID: 9179426
[TBL] [Abstract][Full Text] [Related]
14. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
[TBL] [Abstract][Full Text] [Related]
15. Percentage of eosinophils with surface CD44 and levels of eosinophil cationic protein in the peripheral blood in children with bronchial asthma and their changes after montelukast therapy.
Kopriva F; Szotkowská J; Ordeltová M; Zápalka M
Allergy Asthma Proc; 2006; 27(4):378-82. PubMed ID: 16948353
[TBL] [Abstract][Full Text] [Related]
16. Assessment of anti-inflammatory effect from addition of a long-acting beta-2 agonist to inhaled corticosteroid.
Shimoda T; Obase Y; Kishikawa R; Mukae H; Iwanaga T
Allergy Asthma Proc; 2016 Sep; 37(5):387-93. PubMed ID: 27657522
[TBL] [Abstract][Full Text] [Related]
17. Saliva and serum eosinophil cationic protein in asthmatic children and adolescents with and without allergic sensitization.
Koh GC; Shek LP; Kee J; Wee A; Ng V; Koh D
J Asthma; 2010 Feb; 47(1):61-5. PubMed ID: 20100023
[TBL] [Abstract][Full Text] [Related]
18. Serum Eosinophilic Cationic Protein Is a Reliable Biomarker for Childhood Asthma.
Rydell N; Nagao M; Movérare R; Ekoff H; Sjölander A; Borres MP; Fujisawa T
Int Arch Allergy Immunol; 2022; 183(7):744-752. PubMed ID: 35144256
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of asthma resistant to moderate dose inhaled corticosteroid treatment on bronchial hyperresponsiveness.
Fujimoto K; Yamaguchi S; Urushibata K; Hanaoka M; Koizumi T; Honda T; Kubo K
Intern Med; 2006; 45(14):843-9. PubMed ID: 16908940
[TBL] [Abstract][Full Text] [Related]
20. Presence of rhinovirus in the respiratory tract of adolescents and young adults with asthma without symptoms of infection.
Öhrmalm L; Malinovschi A; Wong M; Levinson P; Janson C; Broliden K; Alving K
Respir Med; 2016 Jun; 115():1-6. PubMed ID: 27215496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
